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The mitochondrial calcium uniporter (MCU) is a highly selective calcium channel localized to the inner mitochondrial membrane. Here, we describe the structure of an MCU orthologue from the fungus Neosartorya fischeri (NfMCU) determined to 3.8 Å resolution by phase-plate cryo-electron microscopy. The channel is a homotetramer with two-fold symmetry in its amino-terminal domain (NTD) that adopts a similar structure to that of human MCU. The NTD assembles as a dimer of dimers to form a tetrameric ring that connects to the transmembrane domain through an elongated coiledcoil domain. The ion-conducting pore domain maintains four-fold symmetry, with the selectivity filter positioned at the start of the pore-forming TM2 helix. The aspartate and glutamate sidechains of the conserved DIME motif are oriented towards the central axis and separated by one helical turn. The structure of NfMCU offers insights into channel assembly, selective calcium permeation, and inhibitor binding.
Mitochondria can take up large amounts of calcium from their environment, which can modulate ATP production, alter cytoplasmic Ca 2+ dynamics, and trigger cell death 1, 2 . Calcium enters the mitochondrial matrix through the mitochondrial calcium uniporter, a highly selective calcium channel that is localized to the inner mitochondrial membrane 3 . In humans, the uniporter is a protein complex, or 'uniplex' , consisting of at least four components: the ion conducting pore (MCU) 4, 5 , an essential membrane spanning subunit (EMRE) 6 , and peripheral membrane gate-keeping proteins (MICU1 and MICU2) 7, 8 . Whereas MCU is found in all major eukaryotic taxa, EMRE is metazoan-specific and is required for the conductivity of MCU in these organisms 6, 9 . By contrast, the MCU homologue in Dictyostelium, whose genome lacks EMRE, is sufficient to operate as a pore-forming channel 10 . Uniporter activity has diverged in fungi, even being lost entirely in certain lineages such as Saccharomyces cerevisiae 11 . In most fungi, genome sequence analysis indicates that the pore-forming MCU is the only component of the uniporter 12 and is likely to represent the minimal channel component of the uniporter for calcium uptake. A recent study used functional mutagenesis to demonstrate that the MCU orthologue from the fungus Aspergillus fumigatus can mediate Ca 2+ transport into mitochondria 13 .
Notably, MCU exhibits no discernible sequence homology to other cation channels 12 , making it difficult to predict its structure and function using computational tools. Although the structures of various isolated MCU domains or the auxiliary component of the uniplex have been reported-the NTD of human MCU 14, 15 , the pore domain of an N-terminal deletion of the C. elegans MCU (cMCU-∆NTD) 16 , and human MICU1 17 -fundamental questions about the channel's assembly, gating, and ion permeation remain unanswered. The recent NMR structure of cMCU-∆NTD revealed a pentameric channel pore with an occluded ion pathway, and EMRE was suggested to be the key to driving the pore from being in the occluded to an open, ion-conductive state 16 ; however, there are no structural data on metazoan MCU and EMRE together. Mounting evidence for the pathophysiological relevance of the uniporter complex 1, 18 has provided further impetus for determination of the structure of the intact channel. To address these longstanding questions, we determined the cryo-EM structure of an MCU homologue from N. fischeri (NfMCU) and also performed in-depth functional studies on this channel. The structure defines the architecture of the channel subunit of the MCU and provides insights into channel assembly and function.
Biochemistry and structure determination
The architectural and functional complexity of metazoan MCU led us to take a reductionist approach and to characterize MCU orthologues from fungi, whose genomes encode only the ion-conducting pore subunit 12 , with the goal of understanding the basic principles that govern channel assembly and function. Among those tested, the 488-residue wild-type MCU orthologue from N. fischeri, NfMCU, showed the best biochemical properties in terms of protein expression and stability and was modified for structural studies (see Methods). Unlike the pentameric cMCU-∆NTD from the NMR study 16 , NfMCU purified as a tetramer in solution (Extended Data Fig. 1 ). Additionally, it conferred uniporter function to bacteria, and NfMCU proteoliposomes recapitulated the voltage-dependent Ca 2+ uptake property of the MCU 19 (see Methods and Extended Data Fig. 2 ).
Determination of the structure of NfMCU using single particle cryo-EM was technically challenging for the following reasons: small protein size of 180 kDa for a channel tetramer; symmetry mismatch between the pore and soluble domains; and an elongated shape with minimal features. In addition, detergent-solubilized NfMCU aggregated when frozen and NfMCU in amphipols exhibited orientation bias. We first overcame the stability issue by reconstituting the channel into nanodiscs but, owing to the channel's flexibility in nanodiscs, whose size is much larger than the transmembrane part of the channel, we could only determine the structure to around 15 Å resolution. This led us to attempt reconstitution using the newly developed scaffolding protein saposin (see Methods) 20 , which we rationalized could adapt its Article reSeArcH oligomerization to maintain NfMCU in an artificial lipid bilayer that is proportional to the channel's smaller transmembrane domain. NfMCU reconstituted in saposin yielded a marked improvement in the structure to an overall resolution of 4.6 Å; however, several parts of the channel were poorly resolved, probably owing to inaccurate particle alignment stemming from the inherently low contrast of small particles. Finally, we used a Volta phase plate to image the NfMCU saposin complex, which ultimately allowed us to determine the structure to an overall resolution of 3.8 Å according to the gold-standard Fourier shell correlation (FSC) = 0.143 criterion (Extended Data Fig. 3 , Extended Data Table 1 and Methods).
Consistent with our biochemical analysis of NfMCU in detergent, the EM map unambiguously showed tetrameric assembly of NfMCU (Fig. 1a ). The map was of sufficient quality for model building of major parts of the protein (Extended Data Fig. 4 and Methods). However, parts of the N and C termini, as well as the long loop in the NTD, were disordered and were not modelled in the final structure (see Methods). The EM map also revealed clear electron density for the 81-residue saposin, which we modelled as poly-alanine (Extended Data Fig. 5 ). Six saposin molecules-each forming a C-shaped clamp oriented at an angle of approximately 45° to the central axis-encircle the lipid bilayer to stabilize NfMCU. Thus, our structure also reveals how saposin oligomerizes to maintain a membrane protein in lipid.
Overall architecture of NfMCU
NfMCU forms an elongated, three-tiered channel tetramer with each tier corresponding to a structural domain: the N-terminal domain (NTD), coiled-coil domain (CCD) and transmembrane domain (TMD) ( Fig. 1b , Extended Data Fig. 6 ). Although NfMCU is tetrameric, it transitions from being four-fold symmetric at the TMD to two-fold symmetric in the NTD, which forms a dimer of dimers ( Figs. 1c, 2a ). Unlike the NMR structure of cMCU-∆NTD, which lacks the NTD and adopts a constricted architecture, NfMCU is architecturally open, with large fenestrations in the space defined by the CCD (Fig. 1b , Extended Data Fig. 7a ). Sitting atop the NTD, the CCD resembles pillars supporting the TMD. The tight packing among the four NTD subunits, as well as the exceptionally long CC1 helix that extends into TM1, dictates the spacing among the four CCDs, thereby, creating a highly solventaccessible space below the ion conduction pathway.
There are several major differences between the structures of NfMCU and cMCU-∆NTD (Extended Data Fig. 7a, b ). In addition to their oligomeric states and overall architecture, the secondary structural elements between the two structures are also quite different. The CC1 and TM1 form a single extended helix in NfMCU but are comprised of five short, broken helices in cMCU-∆NTD (Extended Data Fig. 7b ). These structural differences are unlikely to be caused by the different origins of the two channels, as the CCD, TMD and selectivity filter are highly conserved among MCU orthologues 12 (Extended Data Fig. 6 ). We suspect that the missing NTD and the use of a denaturing detergent such as fos-choline to extract and purify protein from inclusion bodies in the NMR study contributed to these discrepancies.
Luminal soluble domains
The NTD and CCD constitute the luminal soluble domains of NfMCU. Despite the poor sequence conservation of the NTD among MCU orthologues 12 (Extended Data Fig. 6 ), the structures of the NTDs from NfMCU and human MCU are strikingly similar 14, 15 . Consisting of seven β-strands (β1-7) and two helices (α1 and 2), each NTD forms a barrel enclosed by the seven-stranded β-sheet and the α1 helix, with the α2 helix sitting atop the barrel (Extended Data Fig. 7b ). Four NTDs form a well-packed tetrameric ring in a dimer of dimers configuration with two-fold symmetry ( Fig. 2a ). Inter-subunit interactions are defined by two types of interface. Interface I involves primarily hydrogen bonding between main chain atoms on β5 of one subunit and β3 of a neighbouring subunit ( Fig. 2b) , whereas interface II is stabilized by hydrogen bonding between polar side chains ( Fig. 2c ). A similar dimerization at interface I is also observed in the crystal structure of HsMCU NTD (Extended Data Fig. 7c ), thus highlighting the structural conservation between NfMCU and human MCU. The tetrameric assembly of the NTD implies that this domain has a role in maintaining the channel's architectural integrity. However, its functional importance is not entirely clear on the basis of studies of human MCU 14, 16 and, thus, warrants further investigation.
The CCD consists of four helices-CC1, α3, CC2 and α4 ( Fig. 1d , Extended Data Fig. 6 ). The first coiled-coil (CC1) forms an exceptionally long α-helix that curves with respect to the central axis as it extends from the NTD towards the TMD, transitioning seamlessly into TM1. A juxtamembrane loop (JML)-approximately 10 residues-and the α3 Article reSeArcH helix connect the end of TM2 to the second coiled-coil (CC2) in two distinct conformations between two neighbouring subunits ( Fig. 1d ). In one subunit, the loop runs parallel to the membrane and the α3 helix runs almost parallel to CC1, while in the other subunit the loop extends nearly perpendicularly from the membrane and the α3 helix becomes more perpendicular to CC1. The CC2 helix runs nearly parallel to CC1 to form a coiled-coil and the CCD ends with the short α4 helix that runs perpendicularly to the coiled-coil, jutting away from the central axis ( Fig. 1d ).
Ion-conducting pore
The NfMCU pore is architecturally unique as compared to classical two-transmembrane tetrameric cation channels such as KcsA 21 , whose outer TM1 helix wraps around the inner pore-forming TM2 helix, generating an inverted teepee-shaped ion conduction pore. Pillared by four TM1s, the transmembrane helices of NfMCU enclose a coneshaped ion conduction pore with a wider opening at the luminal side ( Figs. 3, 4a ). Notably, the pore-forming TM2 makes very little contact with the TM1 from the same subunit, but rather interacts extensively with a neighbouring TM1 ( Fig. 3a ). Consequently, there is a wide gap between TM1 and TM2 within each subunit at the luminal half of the membrane, which we expect to be sealed by lipid.
NfMCU also lacks the canonical re-entrant pore loop and helix that define the selectivity filter of tetrameric cation channels; instead, the filter residues constitute the first helical turn of TM2. The conserved acidic residues of the DIME motif, which is 369 DTME 372 in NfMCU, point towards the central axis and are separated by about one helical turn ( Fig. 4 ). Four D369 residues encircle the cytosolic pore entrance of NfMCU with a diagonal distance of about 8.0 Å between carboxylate oxygen atoms. The side chains of E372 form the narrowest part of the filter, with the narrowest opposing carboxylate oxygens measuring about 4.5 Å (Fig. 4b ). As NfMCU was maintained in 1 mM CaCl 2 throughout sample preparation, we also observed a strong electron density at the centre of the E372 ring, which we assigned as a Ca 2+ chelated by two opposing E372s in a bidentate manner with ion-ligand distances between 2.2 and 2.5 Å, which are optimal for Ca 2+ coordination ( Fig. 4c, d) . The protein packing around the filter region also provides insights into the evolutionary conservation of several residues close to the DIME motif. W368 intercalates between TM2 of each subunit with its indole ring oriented nearly vertically; its phenyl ring forms CH-π interactions with the highly conserved P373 in a stacked-like configuration 22,23 , while the amino group of the pyrrole ring forms intra-and intermolecular hydrogen bonds with the carboxylate oxygen of E372 ( Fig. 4c, d ). Replacement of W368 or P373 with alanine resulted in non-functional channels (Fig. 4e ). Thus, the region constituting the selectivity filter of NfMCU is tightly packed and conformationally rigid.
Beyond the selectivity filter, the pore opens into a large, mainly hydrophobic cavity that widens towards the base of the ion conduction pathway rather than constricting (as seen among canonical tetrameric cation channels) ( Fig. 4a ). Whether gating occurs within the ionconducting pore is unclear and warrants further investigation. However, our in vitro 45 Ca 2+ flux assay and bacterial Ca 2+ uptake assay seem to suggest that NfMCU functions as a constitutively open channel, as the only condition required to stimulate Ca 2+ uptake is an electrochemical gradient. Our speculation is also supported by the general consensus that Ca 2+ activation of the human uniporter is mediated by MICU1 and MICU2 rather the channel itself 24-27 .
Ca 2+ permeation and inhibitor binding
The proximity of the two rings of acidic residues-D369s and E372swithin the selectivity filter of NfMCU suggests a two-site, single-file pore for selective Ca 2+ permeation in MCU, which is conceptually similar to the classical ion conduction model for the voltage-gated Ca 2+ channel (Ca V ) 28,29 . With a larger diameter, the ring of D369s at the cytosolic entrance encircles a low-affinity Ca 2+ site (site 1) for hydrated ion. The site is likely to be non-specific, but to show a preference for Ca 2+ given the highly negative charge of the ring. The narrow ring consisting of E372s forms the high-affinity, Ca 2+ -selective site (site 2) with the acidic side chains directly chelating Ca 2+ , analogous to the high-affinity Ca 2+ site formed by the EEEE locus of Ca V channels 30 . In addition, the structural constraint of E372 forces the carboxylate side chains to be near each other, making an empty site 2 energetically unfavourable owing to electrostatic repulsion. We suspect that, to mitigate this effect, site 2 is constitutively bound to Ca 2+ with high affinity, which can be accomplished under physiological conditions because MCU has high affinity for Ca 2+ (≤2 nM) 3 . Thus, a potential mechanism for Ca 2+ TM2  TM1′  TM1   TM1  TM1   TM1  TM1   TM2   TM2   TM2   TM2   TM1  TM2   TM2   TM2   TM2   TM1   TM1  TM1 Pore entrance Pore exit a b
Article reSeArcH transport in MCU is likely to follow a similar model to that proposed for Ca V channels ( Fig. 5a ): Ca 2+ binds constitutively to site 2 under physiological conditions and blocks the permeation of Na + or K + . With increasing cytosolic Ca 2+ concentration, Ca 2+ gradually occupies site 1 and, thereby, provide the necessary electrostatic repulsion between sites 1 and 2 to lower the affinity of the site 2 Ca 2+ , allowing it to be readily knocked off and to move into the water-filled vestibule directly below the filter. This Ca 2+ permeation cycle repeats as the Ca 2+ from site 1 hops to site 2, freeing site 1 to bind a new Ca 2+ . The presence of the low-affinity site external to the high-affinity site may also explain the inward rectification of Ca 2+ permeation observed in MCU.
The two-site model implies that the high affinity site 2 is essential for Ca 2+ selectivity while the low affinity site 1 is less specific but necessary for efficient Ca 2+ permeation. We tested the roles of the acidic residues at both sites for Ca 2+ permeation in NfMCU using our bacterial uptake assay. We first examined the effect of neutralizing the two acidic residues individually (D369N and E372Q). Consistent with observations in human MCU 4, 16 , the E372Q mutant no longer conducts Ca 2+ , and the D369N mutant exhibited a slight reduction in Ca 2+ uptake ( Fig. 5b , Extended Data Fig. 8 ). We also investigated whether disruption of the ion coordination distance had any effect on channel function. Notably, a D369E mutant showed about 50% greater Ca 2+ uptake compared to the wild type, whereas the E372D mutant remained nonfunctional. A similar D261E mutation in human MCU-equivalent to the D369E mutation in NfMCU-showed a slight reduction in calcium uptake 16 . Mutation of D369 to threonine or glutamine yielded nonfunctional channels. These data confirm that site 2 (E372), which is essential for specific Ca 2+ binding, is highly sensitive to mutations, whereas the non-specific site 1 (D369) is more tolerant to mutations.
The structure of NfMCU also offers an opportunity to probe the mechanism of binding of Ru360, an analogue of ruthenium red that specifically blocks Ca 2+ uptake by MCU. In human MCU, a serine (S259) two residues before the DIME motif was initially shown to be important for Ru360 binding 4 , as an alanine mutation at this site conferred resistance to the drug while still allowing calcium transport. In NfMCU, the equivalent residue is a glycine. Studies on cMCU-∆NTD identified the aspartate of the DIME motif as a second key residue for Ru360 binding 31 , which we suspect is the primary Ru360 binding site for NfMCU because the DIME motif is conserved across all MCU orthologues. Neutralizing the aspartate (D369N) weakened Ru360 blocking, whereas maintaining the charge but reducing the pore diameter at site 1 (D369E) eliminated Ru360 blocking (Fig. 5c, d) . This result confirms that D369 in NfMCU forms the primary blocking site for Ru360, whose binding is dictated by the charge as well as the pore size at site 1.
Conclusion
Thus, the structure of NfMCU provides a model of an intact mitochondrial calcium uniporter determined to near-atomic resolution, providing new insights into channel assembly and function. Contrary to the structure of cMCU-∆NTD, NfMCU functions as a tetrameric calcium channel, whose pore is poised for rapid ion conduction. In essence, the channel provides a rather finite barrier measuring about 6 Å-the distance separating the filter aspartate and glutamate-that Ca 2+ must traverse from the intermembrane space to the mitochondrial matrix. The combination of two ion binding sites and a huge electrochemical gradient across the inner mitochondrial membrane provide the necessary driving force for MCU to selectively conduct Ca 2+ . It is notable that early studies of calcium transport demonstrated that mitochondria from diverse eukaryotes have uniporter activity 11 . However, the kinetics and apparent binding affinities of calcium uptake by fungal mitochondria are appreciably different from those of vertebrate mitochondria 11 . While NfMCU reveals the architectural arrangement of the basic channel component of the uniporter, further study is needed to address fundamental questions about metazoan uniporter function, such as how the metazoan MCU evolved to require EMRE for ion conduction and how MICU1 and MICU2 confer Ca 2+ -dependent gating to the uniplex.
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MEthodS
Expression and purification of NfMCU. The construct for NfMCU (NCBI accession number: XP_001266985.1) was codon optimized for expression in E. coli and cloned into the pCOLD II vector 32 . For functional assay, the full-length protein with only the mitochondrial targeting sequence removed (Extended Data Fig. 5 ) was modified to contain an N-terminal 6x-His tag and a thrombin cleavage site (LVPRGS) and then reinserted back into the pCOLD II vector (Takara) using the restriction sites NdeI/XhoI. For structural studies, the NfMCU construct used in the function assay was further truncated by an additional 10 residues each from the N and C termini and then cloned into the pCOLD II vector using the same restriction sites. Although no significant functional difference was observed between the full-length protein and the truncated channel (Extended Data Fig. 1b ), the truncated construct yields a significantly more monodispersed profile on gel filtration and was subsequently used for structural studies (Extended Data Fig. 1a ). All single-site mutants were generated using the Quikchange Site-Directed Mutagenesis Kit (Agilent) and confirmed by DNA sequencing. E. coli (BL21 DE3) were freshly transformed, plated onto LB/ampicillin (LB/Amp) agar, and grown overnight. Colonies were harvested directly from LB/Amp plates to seed LB media (100 µg/mL ampicillin) and grown in shaker flasks at 37 °C in an orbital shaker until the cells reached an OD 600 = 0.37-0.4, at which point they were transferred to another orbital shaker pre-chilled to 15 °C and allowed to grow for another hour before protein expression was induced by addition of IPTG to a final concentration of 0.4 mM. Cells were then grown at 15 °C for 16-18 h before being harvested. The cell pellets were flash frozen in liquid nitrogen and stored at −80 °C.
To purify NfMCU, the cell pellets were resuspended in lysis buffer (50 mM Tris pH 8, 300 mM NaCl, 1 mM CaCl 2 ), supplemented with protease inhibitors (1 µg/mL each of DNase I, pepstatin, leupeptin and aprotinin, and 1 mM PMSF), and then homogenized on ice. To remove inclusion bodies and misfolded protein, the homogenate was centrifuged at 10,000 × g for 20 min at 4 °C. The supernatant was harvested and NfMCU was extracted with 1% (w:v) n-dodecyl-β-D-maltopyranoside (DDM, Anatrace) by gentle agitation for 1 h on ice. After extraction, the supernatant was collected following a 30-min centrifugation at 21,000 × g at 4 °C and then incubated with Ni-NTA resin (Qiagen) with gentle agitation on ice for 1 h. The resin was collected on a disposable gravity column (Bio-Rad), washed with wash buffer A (lysis buffer + 1 mM DDM) for 3 column volumes and then with wash buffer B (lysis buffer + 1 mM DDM + 30 mM imidazole) for 10 column volumes. NfMCU was eluted with wash buffer C (lysis buffer + 1 mM DDM + 300 mM imidazole). Thrombin was added at a ratio of 1 unit of thrombin per 1 L culture of bacterial cell pellet; the sample was allowed to incubate at 20 °C, overnight, to remove the His-tag. NfMCU was then concentrated and further purified by size exclusion chromatography on a Superdex 200 10/300 GL column (GE Heathcare) pre-equilibrated with buffer D (20 mM HEPES pH 7.5, 300 mM NaCl, 1 mM CaCl 2 , 1 mM DDM). The main peak (eluting around 11 mL) was then collected for further biochemical and structural analysis. Reconstitution of NfMCU into saposin. We were unsuccessful in reconstituting NfMCU following the original protocol 20 , likely due to the recommended step of heat shocking the sample during reconstitution. We thus made some modifications to the protocol, which we believe is better suited for more sensitive or less stable membrane proteins. Our reaction consists of the following components mixed at a molar ratio of 1:3:10 (NfMCU: saposin: E. coli total lipids). As a substitution for the recommended heat-shock step 20 , saposin was destabilized by incubation with sodium cholate (15 mM final concentration) with rotation at 4 °C for 1 h. Purified NfMCU (concentrated to 100 µM) was then added to the reaction and allowed to rotate at 4 °C for 1 h before addition of BioBeads (BioRad) to remove detergents. The reaction was incubated with BioBeads for 3-4 h at 4 °C, and BioBeads exchange was performed a total of 3 times with each incubation step lasting 3-4 h at 4 °C. The reconstituted NfMCU saposin complex was separated from empty saposin complex and aggregates by gel filtration chromatography on a Superdex 200 10/300 GL column (GE Heathcare) pre-equilibrated with buffer E (20 mM HEPES pH 7.5, 300 mM NaCl, 1 mM CaCl 2 , 2% glycerol). The main peak (eluting around 11 mL) was then collected for structural analysis. EM data acquisition. Prior to freezing grids, the NfMCU saposin complex (concentrated to 0.6 mg/mL) was incubated with 50 µM Ru360 on ice for 30 min. The cryo-EM grids were prepared by applying 3 µL of the NfMCU-saposin-Ru360 complex to a glow-discharged Quantifoil R1.2/1.3 300-mesh gold holey carbon grid (Quantifoil, Micro Tools GmbH, Germany) and blotted for 4.0 s under 100% humidity at 4 °C before being plunged into liquid ethane using a Mark IV Vitrobot (FEI). Micrographs were acquired on a Titan Krios microscope (FEI) operated at 300 kV with a K2 Summit direct electron detector (Gatan), using a slit width of 20 eV on a GIF-Quantum energy filter as well as a Volta phase plate following the same approach for phase plate data collection as previously described 33 . EPU software (FEI) was used for automated data collection following standard FEI procedure. A calibrated magnification of 59,523× was used for imaging, yielding a pixel size of 0.84 Å on images. The defocus was set at −0.5 µm. Each micrograph was dose-fractionated to 30 frames under a dose rate of 4 e − /pixel/s, with a total exposure time of 12 s, resulting in a total dose of about 60 e − /Å 2 . Image processing. For the NfMCU phase plate data set, motion correction was performed using the MotionCorr2 program 34 , and the CTF parameters of the micrographs were estimated using the GCTF program 35 . All other steps of image processing were performed using RELION 36 . Initially, about 1,000 particles were manually picked from a few micrographs. Class averages representing projections of NfMCU in different orientations were selected from the 2D classification of the manually picked particles, and used as templates for automated particle picking from the full data set of 2,470 micrographs. The 526,554 extracted particles were binned 3 times and subjected to two rounds of 2D classification, and a total of 355,929 particles were finally selected for 3D classification using the initial model generated by RELION as the reference. Two of the 3D classes showed good secondary structural features and their particles were selected, combined and re-extracted into the original pixel size of 0.84 Å. After 3D refinement with C2 symmetry imposed and particle polishing, the resulting 3D reconstructions from 128,231 particles yielded an EM-map with a resolution of 3.8 Å. The transmembrane domain showed poor density, indicating a local structural heterogeneity. Therefore, we performed a focused 3D classification with density subtraction in order to improve the density of the transmembrane domain 37 . In this approach, the density corresponding to the soluble domains of the channel as well as the belt-like density from saposin was subtracted from the original particles. The subsequent 3D classification on the modified particles was carried out by applying a mask around the transmembrane domain and having all the orientations fixed at the value determined in the initial 3D refinement. After this round of classification, one class (83,343 particles) with better density in the transmembrane domain was selected for 3D refinement, yielding an EM map of 3.8 Å in which the entire transmembrane domain can be modelled. All resolutions were estimated by applying a soft mask around the protein density and the gold-standard FSC = 0.143 criterion. ResMap 38 was used to calculate the local resolution map. Model building, refinement, and validation. De novo atomic model building was conducted in Coot 39 . Since the crystal structure of the NTD of human MCU 14 (PDB: 4XTB) fits nicely in the EM map, it was used as a guide to build the NTD of NfMCU. Amino acid assignment was achieved based on the clearly defined density for bulky residues (Phe, Trp, Tyr, and Arg). Models were refined against summed maps using phenix.real_space_refine 40 , with secondary structure restraints applied. The model was validated using previously described methods to avoid overfitting 41, 42 . The 3.8 Å EM density map of NfMCU allowed us to construct a model containing the following residues: chain A, B: 124-200, 258-399, and 406-461; chain C, D: 124-196, 259-396, and 404-461. Although we added Ru360 in our sample with the hope of seeing how it blocks the channel pore, its density was not visible in the structure. One main reason could be the symmetry mismatch. As the MCU pore entrance has fourfold symmetry, Ru360 could bind to the pore in four different orientations, causing its density to be averaged out. The statistics for the model's geometries were generated using MolProbity 43 . Pore radii were calculated using the HOLE program 44 . All the figures were prepared in PyMol 45 or Chimera 46 . Bacterial calcium uptake assay. E. coli expressing NfMCU were grown as described above with the exception that protein induction was allowed to proceed for 16 h, at which time the cells were harvested, centrifuged at 4000 × g for 10 min at 4 °C, and the media was discarded. To remove residual media, the cell pellet was resuspended in ice-cold buffer (50 mM HEPES pH 7.4, 150 mM KCl) and then centrifuged again (4000 × g for 10 min at 4 °C) and the supernatant was discarded. To prepare the bacteria for calcium uptake measurements, the bacteria were treated as though they were mitochondria and prepared as previously described for the purification of mitochondria from yeast 47 but with slight modifications. To remove residual Ca 2+ , the cells were resuspended to a final concentration of 10 mg/mL in ice-cold bacteria prep buffer (0.6 M D-mannitol, 10 mM KH 2 PO 4 , 20 mM HEPES pH 7.4, 5 mg/mL bovine serum albumin) plus 1 mM EDTA and allowed to shake gently on ice for 30 min. To replenish any Mg 2+ that was chelated by EDTA treatment, 2 mM MgCl 2 was then added into the cell resuspension followed by gentle shaking on ice for another 30 min. The cells were then centrifuged (4000 × g for 10 min at 4 °C) and the supernatant was discarded. The cells were centrifuged again (4000 × g for 3 min at 4 °C) and residual buffer was removed with a pipette. The wet weight of the bacteria was measured with a digital balance (typical yield is ~80 mg of bacteria per 30 mL culture of bacteria). The cells were then resuspended in ice-cold reaction buffer (0.6 M D-mannitol, 20 mM HEPES pH 6.8, 10 µM EGTA, 0.5 mg/mL bovine serum albumin) to a final concentration of 10 mg/mL and were used immediately for calcium uptake measurement.
To measure calcium uptake, we relied on the highly negative membrane potential across the plasma membrane of E. coli 48 and used the fluorescent calcium indicator Oregon Green BAPTA-6F (Life Technologies), which was added to a final concentration of 1 µM (from aliquots of a 500 µM stock kept at −20 °C) to cells resuspended in reaction buffer, to monitor the Ca 2+ concentration changes Article reSeArcH over time using fluorescence signal-a conventional approach for monitoring mitochondrial calcium uptake in the field 4, 5 . For calcium uptake measurements, 100 µL of cell suspension was added to a 96-well plate (Corning) and fluorescence was monitored in a Molecular Devices SpectraMax M3 plate reader (excitation/ emission: 485 nm/535 nm). Baseline fluorescence was measured for all samples at the start of each reaction for 60 s followed by addition of 5 µL CaCl 2 stock to the 100 µL reaction in any experiment to reach the desired concentration. With the exception of the experiment in Fig. 1A , where the bacteria were pulsed 3 times with 20 µM CaCl 2 , all measurements were from samples pulsed only once with the concentration of CaCl 2 indicated in the figure legend. Fluorescence was monitored for 4 min to assess calcium uptake.
For the inhibition experiments (either with GdCl 3 or Ru360), the inhibitor was added to 1000 µL of cell suspension to the highest desired concentration of inhibitor for the experiment and this cell suspension was then used as a stock to dilute into a cell suspension without any inhibitor added (to a final volume of 100 µL) to obtain a series of cells in the desired inhibitor concentration. The samples were then pulsed with 50 µM CaCl 2 and fluorescence was monitored for 4 min.
To ensure protein expression was comparable among the NfMCU mutants tested in our uptake assay, western blot analysis was performed on each sample used for each experiment. Extended Data Fig. 8 shows representative western blots of an experimental trial using the NfMCU mutants referred to in this study. Mouse anti-His antibodies (Qiagen) was used to detect NfMCU expression and mouse anti-E. coli RNA polymerase alpha or anti-RpoA (Santa Cruz Biotechnology) was used as a loading control. HRP-conjugated sheep anti-mouse antibodies were used as the secondary antibodies (GE Healthcare).
All data were analysed in GraphPad Prism 7 (GraphPad Software, Inc.). To obtain the rate of calcium uptake, the linear phase of the uptake measurement-the first 45-60 s of the reaction following CaCl 2 administration-was determined by fitting the data to a linear regression equation in GraphPad Prism; the slope of the fit is taken as the rate of calcium uptake. Further analysis such as normalization are indicated in the figure legend. To obtain the IC 50 for Ru360, the relative calcium uptake rates were fitted to a dose-response curve in GraphPad Prism. Radioactive 45 Ca flux assay. In light of the contradiction of the oligomeric state between NfMCU and cMCU-∆NTD, we designed an in vitro functional assay by reconstituting our purified tetrameric channel into liposomes. Unable to obtain currents of NfMCU by electrophysiology-probably due to the channel's small conductance-we performed a radioactive 45 Ca 2+ flux assay on proteoliposomes loaded with 150 mM KCl.
NfMCU was reconstituted into lipid vesicles using a similar protocol as described 49 . E. coli total lipid (Avanti) was prepared following standard protocol and then solubilized in dialysis buffer (50 mM HEPES pH 7.4, 150 mM KCl) supplemented with 40 mM n-decyl-β-D-maltopyranoside (DM, Anatrace). Purified NfMCU in DDM (at ~1 mg/mL) was mixed with the DM-solubilized E. coli total lipid at a ratio of 1:100 (w:w, protein:lipids). NfMCU and lipid mixture were incubated with gentle rotation at 4 °C for 1 h and then dialysed (using dialysis tubing with a molecular weight cutoff of 12,000-14,000 Da (Spectra/Por) against 1 L of dialysis buffer at 4 °C to remove detergent. Fresh dialysis buffer (1 L each time) was exchanged every 18-20 h for a total of 3 exchanges. Following dialysis, NfMCU proteoliposomes were divided into 100 µL aliquots, flash frozen in liquid nitrogen, and stored at −80 °C. For all flux assays, three separate batches of bacteria were grown to express NfMCU. The protein was then purified individually and used immediately for reconstitution into liposomes.
The 45 Ca 2+ flux assay was performed following the same procedures as previously described but with slight modifications 49 . NfMCU proteoliposomes were thawed and sonicated in a bath sonicator for 60 s at 15 s intervals before the assay. 100 µL samples were passed through a pre-spun Sephadex G-50 fine gel filtration column (1.5 mL bed volume in a 5 mL disposable spin column) swollen in flux buffer (50 mM HEPES pH 7.4, 150 mM KCl or NMDG). The resulting 160 µL of proteoliposome eluent was collected and added to 300 µL of reaction buffer (flux buffer + 0.2 µM valinomycin + 83 µM 45 CaCl 2 ) to initiate the reaction. At various time points, 75 µL of this reaction mixture was passed through a prespun Sephadex G-50 fine gel filtration column as previously described to remove extra-liposomal 45 Ca 2+ and stop the flux. The eluent was mixed with 10 mL scintillation cocktail and its radioactivity was measured in a scintillation counter.
For the Ru360 inhibition experiments, NfMCU proteoliposomes in flux buffer (50 mM HEPES pH 7.4, 150 mM NMDG) were mixed with reaction buffer containing varying concentrations of Ru360 (dissolved in NMDG flux buffer + 0.2 µM valinomycin + 83 µM 45 CaCl 2 ). The reaction was allowed to proceed for 30 min, after which the reaction was stopped by passing 75 µL of the reaction through a pre-spun Sephadex G-50 fine gel filtration column as previously described. To determine the relative calcium uptake by NfMCU proteoliposomes, the scintillation count for each sample was normalized to the sample without any Ru360 in the reaction. Supplementary Fig. 1 .
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Sample size
All fluorescent and radioactive calcium uptake assays were repeated at least 3 times. The sample size was determined based on the reproducibility of the data. As all assays yielded consistent results, the sample size was sufficient to provide accurate measurement.
Data exclusions 3-D classification yielded multiple 3-D reconstruction maps. Only the particles that gave rise to homogeneous density were selected, combined and used in the final reconstruction and refinement. Details are described in the flowchart of Extended Data Figure 3 and Methods.
Replication
All experimental findings were reliably reproduced with consistent results.
Randomization For structure refinement and model validation, all particles were randomly split into two groups, one group was used for refinement and the other for validation. For the fluorescent calcium uptake assay, calcium measurement was performed on a population of bacteria expressing the NfMCU channel. For the radioactive calcium flux assay, calcium uptake measurement was performed on a population of purified NfMCU channels that have been reconstituted into liposomes in random orientation.
Blinding
The investigators were blinded to group allocation during data collection and analysis.
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Validation
Mouse anti-penta His antibody: Qiagen reported that the IgG antibodies were produced "in vitro" and "isolated from serum-free hybridoma cell cultures, ensuring preparations free of viruses, mycoplasma, and contaminating immunoglobulins." The specificity of the antibodies "was determined by epitope mapping using libraries of peptides synthesized directly onto nitrocellulose." (Qiagen's QIAexpress Detection and Assay Handbook: https://www.qiagen.com/us/resources/resourcedetail? id=a8d20bf6-b88c-436b-a7be-de66b5dd70fd&lang=en) HRP conjugated sheep anti-mouse antibody: GE Healthcare reported that the antibody was produced by "hyper-immunizing
